Mercy Medical Center

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Mercy Medical Center sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).

13 total trials 2 currently recruiting 9 completed top decile by trial count

Mercy Medical Center: 13 sponsored US clinical trials, 2 recruiting.

Mercy Medical Center sponsors 13 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 9 completed. 3 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pseudomyxoma Peritonei, with 1 trials.

Top-decile sponsor footprint

Mercy Medical Center ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

13 total, page 1 of 1

RECRUITING

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

NCT06750731
RECRUITING Phase 4

Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis

NCT04588077
ACTIVE NOT RECRUITING Phase 2

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

NCT02387203
ACTIVE NOT RECRUITING Phase 2

HOT: HIPEC in Ovarian Cancer as Initial Treatment

NCT02124421
COMPLETED NA

Evaluation of a Double Balloon Interventional Platform (DiLumen) for Complex Colonic ESD

NCT03846609
COMPLETED NA

Effectiveness and Safety of the Colonoscopy With "Visualization" Balloon

NCT02117232
COMPLETED NA

Effectiveness and Safety of the Endoscopic Removal of Large and Flat Colonic Polyps With LumenR RetractorTM

NCT02051465
COMPLETED NA

Promoting Fetal Movement Monitoring: Improving Birth Outcomes

NCT01844011
COMPLETED Phase 3

Technology Enhanced Nurse Navigator Trial (TENN Trial)

NCT01596179
COMPLETED NA

A Comparison of Narrow Band Imaging (NBI) and Standard White Light Laparoscopy to Detect Endometriosis

NCT01464775
COMPLETED NA

Duration of Second Stage of Labor Wearing a Dental Occlusion Device

NCT00629369
COMPLETED Phase 3

Fatigue Intervention Trial for Breast Cancer Survivors

NCT00513136
COMPLETED NA

An Intervention to Decrease Fatigue Among Breast Cancer Survivors

NCT00273208

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 2
Phase 4 1

Therapeutic Areas

Pseudomyxoma Peritonei 1
Appendiceal Neoplasms 1
Stage III Ovarian Cancer 1
Primary Peritoneal Carcinoma 1
Fallopian Tube Carcinoma 1
Chronic Liver Disease 1
Hepatitis B 1
Fallopian Tube Cancer 1
Stage IV Ovarian Cancer 1
Ovarian Carcinoma 1

What is open in the Mercy Medical Center pipeline

2 recruiting of 13 indexed (15% open); 9 completed (69%).

Phase mix: 3 late (III/IV) vs 2 early (I/II) (balanced across stages).

Top condition: Pseudomyxoma Peritonei (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Mercy Medical Center: open-pipeline peers nationwide

Peers matched on 13 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Mercy Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 12.912.91313.1 0%5%10%15%20% Total trials Recruiting share Mercy Medical CenterAdaptimmuneAgennixAkili Interactive LabsAlumisArrowhead Regional Medical CenterAurinia PharmaceuticalsBronx VA Medical CenterCandel Therapeutics
Mercy Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Mercy Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 13 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Mercy Medical Center page

13 registered trials is a research-attention snapshot, not an endorsement of Mercy Medical Center or any single study.

  • 2 of Mercy Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Pseudomyxoma Peritonei is the condition Mercy Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pseudomyxoma Peritonei trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Mercy Medical Center pipeline card: 13 registered trials from official public datasets.Report a data error.